Markets:

Overview

News

Currencies

International

Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

64.75 -1.10 (-1.67%)

Streaming Delayed Price Updated: 3:37 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Uncover the latest developments among S&P500 stocks in today's session. ↗

Today 12:35 EST

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies.

Via StockStory

Topics Economy Government

3 Healthcare Stocks We Steer Clear Of

November 24, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...

Via StockStory

Topics Stocks

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

An Overview of Bio-Techne's Earnings ↗

November 04, 2025

Via Benzinga

Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

What's going on in today's session: S&P500 movers ↗

November 20, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value

November 19, 2025

SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has...

Via MarketMinute

Topics Artificial Intelligence Economy Regulatory Compliance

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Multimodal AI Unleashes New Era in Cancer Research: A Revolution in Diagnosis and Treatment

November 10, 2025

Recent breakthroughs in multimodal Artificial Intelligence (AI) are fundamentally reshaping the landscape of cancer research, ushering in an era of unprecedented precision in diagnosis and personalized...

Via TokenRing AI

Topics Artificial Intelligence

Bio-Techne (TECH) Q1 2026 Earnings Call Transcript ↗

November 06, 2025

Bio-Techne (TECH) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Season Echoes: Navigating the Volatility of Corporate Reports

November 05, 2025

The financial markets are once again in the throes of earnings season, a period that consistently proves to be a crucible for individual stock valuations and a significant driver of broader market...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Bio-Techne Corp (NASDAQ:TECH) Shares Drop 7.7% on Q1 Earnings and Revenue Miss ↗

November 05, 2025

Bio-Techne (TECH) stock plunges after missing Q1 FY2026 revenue and EPS estimates, triggering a sharp sell-off in pre-market trading.

Via Chartmill

Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops

November 05, 2025

Life sciences company Bio-Techne (NASDAQ:TECH) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 1% year on year to $286.6 million. Its non-GAAP profit of $0.42 per share was...

Via StockStory

What To Expect From Bio-Techne’s (TECH) Q3 Earnings

November 03, 2025

Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Why Bio-Techne (TECH) Stock Is Up Today

October 31, 2025

Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment...

Via StockStory

Topics Artificial Intelligence Supply Chain World Trade

These S&P500 stocks are moving in today's session ↗

October 27, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday.

Via Chartmill

3 S&P 500 Stocks We’re Skeptical Of

October 24, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

What's going on in today's session: S&P500 movers ↗

October 16, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

October 16, 2025

While the S&P 500 is up 26.5% since April 2025, Bio-Techne (currently trading at $59.58 per share) has lagged behind, posting a return of 19.2%. This may have investors wondering how to approach the...

Via StockStory

Topics Stocks Supply Chain

3 Cash-Producing Stocks We Find Risky

October 09, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

5 Analysts Assess Bio-Techne: What You Need To Know ↗

October 07, 2025

Via Benzinga

Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics Government World Trade

What's going on in today's session: S&P500 movers ↗

October 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

3 Low-Volatility Stocks That Concern Us

October 02, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma

September 30, 2025

Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility

September 30, 2025

As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move...

Via MarketMinute

Topics Economy Government Supply Chain

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.